Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$68.77$132.49
1-Month Range
Month up 9.7%
$74.30$89.20
Daily Price Range
Day down -1.1%
$80.79$82.00
Volume
vs 5M avg
1M5M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$33.1B
Short % of Float—
Employees—
Sales$9,467M
Shares Outstanding406,316,147
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.zts.com
Zoetis Inc — Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health ….· via yahoo
Warnings
2 signals
Live
- Debt/Equity elevated at 280.3
- Negative revenue growth (-1.3%)
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
82
Growth
64
Quality
95
Sentiment
54
Insider Sent.
100
Piotroski F
7
Altman Z
4.6
Consensus rating unavailable — no analyst coverage on file for ZTS.
Price targets unavailable — no 12-month targets on file for ZTS.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on ZTS, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 2 warnings surfacedNov 11, 2026, 6:08 PM UTC